EARNINGS AND TRADING: Iofina hits record iodine production levels
4th Sep 2025 18:28
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 24.00p on 18-09-2025 at 10:45:10 |
|---|---|
| Change | 0.50p 2.13% |
| Buy | 25.00p |
| Sell | 23.00p |
| Last Trade: | Unknown 6,900.00 at 24.00p |
| Day's Volume: | 181,534 |
| Last Close: | 23.50p |
| Open: | 23.90p |
| ISIN: | GB00B2QL5C79 |
| Day's Range | 23.90p - 24.00p |
| 52wk Range: | 16.75p - 28.00p |
| Market Capitalisation: | £46.05m |
| VWAP: | 24.48279p |
| Shares in Issue: | 191.86m |
Sector: Industrial Chemicals
Listed In: FTSE AIM All-Share,
Iofina (IOF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 6,900 | 24.00p | Ordinary |
11:06:16 - 18-Sep-25 |
| Unknown* | 1,041 | 24.00p | Ordinary |
09:55:04 - 18-Sep-25 |
| Buy* | 2,500 | 24.44p | Ordinary |
09:13:00 - 18-Sep-25 |
| Sell* | 1,498 | 23.90p | Uncrossing Trade |
09:00:11 - 18-Sep-25 |
| Buy* | 1 | 25.00p | Ordinary |
08:47:17 - 18-Sep-25 |
| Buy* | 4,100 | 24.50p | Ordinary |
08:44:35 - 18-Sep-25 |
| Buy* | 100,000 | 24.50p | Suspected BUY Trade |
08:43:47 - 18-Sep-25 |
| Buy* | 6,122 | 24.50p | Ordinary |
08:36:09 - 18-Sep-25 |
| Buy* | 9,000 | 24.80p | Ordinary |
08:14:05 - 18-Sep-25 |
| Buy* | 1,000 | 24.80p | Ordinary |
08:12:49 - 18-Sep-25 |
Iofina (IOF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 4th Sep 2025 7:00 am | RNS | Business Update |
| 17th Jul 2025 7:00 am | RNS | H1 2025 Update |
| 9th Jul 2025 7:00 am | RNS | Capital Reduction |
| 9th Jun 2025 5:00 pm | RNS | Result of AGM |
| 14th May 2025 7:00 am | RNS | Notice of AGM and Proposed Capital Reduction |
| 12th May 2025 7:00 am | RNS-R | Investor Presentation |
| 12th May 2025 7:00 am | RNS | Final Results |
| 25th Apr 2025 3:45 pm | RNS | Holding(s) in Company |
| 17th Apr 2025 7:00 am | RNS | Q1 2025 Update |
| 23rd Jan 2025 7:00 am | RNS | Q4 2024 Update |